Search research articles
Contact Us
Filters
Showing results (11-20 of 60) with videos related to
Page
of 6
Sort By:
Frontiers in Pain Research (Lausanne, Switzerland)
|
October 9, 2023
Case report: The lesson from opioid withdrawal symptoms mimicking paraganglioma recurrence during opioid deprescribing in cancer pain
Elena Ruggiero, Ardi Pambuku, Mario Caccese, et al.
Expert Opinion on Biological Therapy
|
August 5, 2018
Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies
Vincenzo di Noia, Ettore D'Argento, Sara Pilotto, et al.
Cancers
|
July 2, 2021
Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study
Debora Olioso, Mario Caccese, Alessandra Santangelo, et al.
American Journal of Clinical Oncology
|
May 12, 2018
Quality of Life Perception, Cognitive Function, and Psychological Status in a Real-world Population of Glioblastoma Patients Treated With Radiotherapy and Temozolomide: A Single-center Prospective Study
Giuseppe Lombardi, Eleonora Bergo, Paola Del Bianco, et al.
Cancer Medicine
|
June 27, 2023
The role of radiation therapy and systemic treatments in meningioma: The present and the future
Mario Caccese, Fabio Busato, Angela Guerriero, et al.
Cancers
|
September 28, 2021
Regorafenib in Recurrent Glioblastoma Patients: A Large and Monocentric Real-Life Study
Giuseppe Lombardi, Mario Caccese, Marta Padovan, et al.
Pituitary
|
September 27, 2025
Clinical presentation, predictive factors and management of patients with Nelson syndrome: a retrospective study
Pierluigi Mazzeo, Giulia Bovo, Alessandro Mondin, et al.
Cancers
|
December 11, 2022
Advanced Adrenocortical Carcinoma: From Symptoms Control to Palliative Care
Elena Ruggiero, Irene Tizianel, Mario Caccese, et al.
Expert Review of Endocrinology & Metabolism
|
March 6, 2023
Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series
Marta Padovan, Giulia Cerretti, Mario Caccese, et al.
Frontiers in Oncology
|
November 6, 2020
Ocular Side Effects of EGFR-Inhibitor ABT-414 in Recurrent Glioblastoma: A Long-Term Safety Study
Raffaele Parrozzani, Giuseppe Lombardi, Edoardo Midena, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 60) with videos related to
Sort By:
Page
of 6
Frontiers in Pain Research (Lausanne, Switzerland)
|
October 9, 2023
Case report: The lesson from opioid withdrawal symptoms mimicking paraganglioma recurrence during opioid deprescribing in cancer pain
Elena Ruggiero, Ardi Pambuku, Mario Caccese, et al.
Expert Opinion on Biological Therapy
|
August 5, 2018
Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies
Vincenzo di Noia, Ettore D'Argento, Sara Pilotto, et al.
Cancers
|
July 2, 2021
Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study
Debora Olioso, Mario Caccese, Alessandra Santangelo, et al.
American Journal of Clinical Oncology
|
May 12, 2018
Quality of Life Perception, Cognitive Function, and Psychological Status in a Real-world Population of Glioblastoma Patients Treated With Radiotherapy and Temozolomide: A Single-center Prospective Study
Giuseppe Lombardi, Eleonora Bergo, Paola Del Bianco, et al.
Cancer Medicine
|
June 27, 2023
The role of radiation therapy and systemic treatments in meningioma: The present and the future
Mario Caccese, Fabio Busato, Angela Guerriero, et al.
Cancers
|
September 28, 2021
Regorafenib in Recurrent Glioblastoma Patients: A Large and Monocentric Real-Life Study
Giuseppe Lombardi, Mario Caccese, Marta Padovan, et al.
Pituitary
|
September 27, 2025
Clinical presentation, predictive factors and management of patients with Nelson syndrome: a retrospective study
Pierluigi Mazzeo, Giulia Bovo, Alessandro Mondin, et al.
Cancers
|
December 11, 2022
Advanced Adrenocortical Carcinoma: From Symptoms Control to Palliative Care
Elena Ruggiero, Irene Tizianel, Mario Caccese, et al.
Expert Review of Endocrinology & Metabolism
|
March 6, 2023
Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series
Marta Padovan, Giulia Cerretti, Mario Caccese, et al.
Frontiers in Oncology
|
November 6, 2020
Ocular Side Effects of EGFR-Inhibitor ABT-414 in Recurrent Glioblastoma: A Long-Term Safety Study
Raffaele Parrozzani, Giuseppe Lombardi, Edoardo Midena, et al.
Page
of 6